Listen Top Shows Blog

Advances in Payload Delivery and Drug Conjugation

Advances in Payload Delivery and Drug Conjugation

Update: 2025-12-12

Share

Description

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss conjugation and bioconjugation approaches to make ASOs and small molecules more tolerable while improving targeting. Technologies discussed include ADCs, PDCs, SMDCs, VDCs, RDCs and AOCs. Specifically they address:

Biological and chemical challenges for these therapies
Building out scalable manufacturing and a regulatory strategy
Hurdles to overcome to get products to market

To learn more about the PODD Conference, please visit Drug-Delivery.org.

Comments

In Channel

What is the State of Clinical Trial Patient Matching Right Now?

What is the State of Clinical Trial Patient Matching Right Now?

2025-12-1940:16

Balancing Innovation and Practicality in Immuno-Oncology Dose Selection

Balancing Innovation and Practicality in Immuno-Oncology Dose Selection

2025-12-1945:12

Leveraging Local HCPs to Decentralize Clinical Research in North Carolina

Leveraging Local HCPs to Decentralize Clinical Research in North Carolina

2025-12-1920:38

Using Patient Engagement and Digital Innovation to Elevate Patient Insights and Outcomes

Using Patient Engagement and Digital Innovation to Elevate Patient Insights and Outcomes

2025-12-1919:59

What to Expect at the 2026 Patients as Partners in Clinical Research Conference

What to Expect at the 2026 Patients as Partners in Clinical Research Conference

2025-12-1805:22

The Role of the CMO in BD and M&A Partnering with Pharma

The Role of the CMO in BD and M&A Partnering with Pharma

2025-12-1227:50

Advances in Payload Delivery and Drug Conjugation

Advances in Payload Delivery and Drug Conjugation

2025-12-1229:59

Building Up a CMO Team as Your Company Evolves

Building Up a CMO Team as Your Company Evolves

2025-12-0132:20

Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles

Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles

2025-12-0129:52

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

2025-11-2415:26

Insights from Tufts CSDD into Evolving Trial Partnerships Models

Insights from Tufts CSDD into Evolving Trial Partnerships Models

2025-11-2416:05

ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma

ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma

2025-11-2419:18

Understanding the Immunological Effects of Radiopharmaceuticals

Understanding the Immunological Effects of Radiopharmaceuticals

2025-11-2418:11

How J&J Is Integrating Patient Centricity Across the Enterprise

How J&J Is Integrating Patient Centricity Across the Enterprise

2025-11-1926:00

Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics

Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics

2025-11-1931:13

What to Expect at the 2026 IO360° Summit

What to Expect at the 2026 IO360° Summit

2025-11-1204:22

CMOs Working Flexibly with Consultants and Fractional Expertise

CMOs Working Flexibly with Consultants and Fractional Expertise

2025-11-0330:55

Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

2025-10-2417:35

How Patient Organizations are Bridging Patient Inclusivity Gaps at the Site-Level

How Patient Organizations are Bridging Patient Inclusivity Gaps at the Site-Level

2025-10-2441:58

How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost

How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost

2025-10-2113:08

00:00

00:00

x

Advances in Payload Delivery and Drug Conjugation

Advances in Payload Delivery and Drug Conjugation

Conference Forum